Abstract | BACKGROUND/AIM:
Primary effusion lymphoma (PEL) is classified as a rare non-Hodgkin's B-cell lymphoma that is caused by Kaposi's sarcoma-associated herpesvirus (KSHV); PEL cells are latently infected with KSHV. PEL is frequently resistant to conventional chemotherapies. Therefore, the development of novel therapeutic agents is urgently required. Nigericin, a H+ and K+ ionophore, possesses unique pharmacological effects. However, the effects of nigericin on PEL cells remain unknown. MATERIALS AND METHODS: RESULTS: Although the three tested ionophores inhibited the proliferation of several B- lymphoma cell lines, nigericin inhibited the proliferation of PEL cells compared to KSHV-negative cells. In PEL cells, nigericin disrupted the mitochondrial membrane potential and caused the release of cytochrome c, which triggered caspase-9-mediated apoptosis. Nigericin also induced both an increase in phosphorylated p38 MAPK and proteasomal degradation of β- catenin. Combination treatment of nigericin with the p38 MAPK inhibitor SB203580 potentiated the cytotoxic effects towards PEL cells, compared to either compound alone. Meanwhile, nigericin did not influence viral replication in PEL cells. CONCLUSION:
|
Authors | Haruka Umeyama, Zenpei Shigemi, Yusuke Baba, Naoko Hara, Tadashi Watanabe, Masahiro Fujimuro |
Journal | Anticancer research
(Anticancer Res)
Vol. 43
Issue 6
Pg. 2455-2465
(Jun 2023)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 37247906
(Publication Type: Journal Article)
|
Copyright | Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
- Nigericin
- beta Catenin
- Antineoplastic Agents
- Ionophores
- p38 Mitogen-Activated Protein Kinases
|
Topics |
- Humans
- Lymphoma, Primary Effusion
(drug therapy, pathology)
- Nigericin
(metabolism, pharmacology, therapeutic use)
- beta Catenin
(metabolism)
- Mitochondrial Membranes
(metabolism, pathology)
- Cell Line, Tumor
- Apoptosis
- Antineoplastic Agents
(pharmacology)
- Herpesvirus 8, Human
(physiology)
- Mitochondria
- Ionophores
(metabolism, pharmacology, therapeutic use)
- p38 Mitogen-Activated Protein Kinases
(metabolism)
|